Parkinson’s Risk Linked to Cymbalta, Celexa, Similar Antidepressants: Study
A new study links a number of antidepressants, including Celexa, Cymbalta, Lexapro and Zoloft, to an increased risk of Parkinson’s disease and other movement disorders.…
«
»
A new study links a number of antidepressants, including Celexa, Cymbalta, Lexapro and Zoloft, to an increased risk of Parkinson’s disease and other movement disorders.…
A case study on a 13 year old girl who suffered Abilify tardive dyskinesia suggests that the movement disorder may be treated by Akineton and other biperiden-based drugs.…
A tentative settlement could resolve thousands of Reglan tardive dyskinesia lawsuits nationwide.…
Antipsychotics such as Abilify and Risperdal are so hard on the body that most patients do not complete treatment, according to the findings of a new study, which suggests that the risks of the drugs may outweigh their benefits.…
A new study warns that antipsychotics may be more likely to cause movement disorders in patients with schizophrenia and depression.…
An Abilify tardive dyskinesia lawsuit has been cleared to move forward, with a federal judge saying there is sufficient evidence to bring failure to warn lawsuits against the manufacturers for involuntary muscle movements.…
The FDA is warning that the ADHD patch, Daytrana, has been linked to reports of skin color loss that are permanent.…
A new Jersey appeals court has cleared the way for some generic Reglan lawsuits over claims of involuntary muscle movement, saying the cases are not preempted by federal law because some generic manufacturers delayed updating warning labels.…
The anti-nausea drug Reglan shows no link to birth defects, according to a new study.…
Hospira has announced a generic Reglan and generic Zofran recall due to potential glass contamination.…